Jewish Hospital, The

Cincinnati, Ohio 45236

0 studies enrolling now · 2 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Hodgkin Disease, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma — Completed